logo

For the Inventor, By the Inventor

Yongin, South Korea

Geun-Hyung Lee

This inventor holds 3 USPTO granted patents. Top assignees: B & C Biopharm, Dongwha Pharm. Ind. Co., Ltd.. Active years: 2003-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geun-Hyung Lee. Retrieved from https://idiyas.com/inventor/geun-hyung-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Anyang-si, KR (2003)
  • Yongin-si, KR (2007)

Company Filing History:

goldMedal2 out of 2 
 
B & C Biopharm
 patents
silverMedal1 out of 13 
 
Dongwha Pharm. Ind. Co., Ltd.
 patents

Years Active: 2003-2007

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7276501 - 6-(4-substituted-anilino)pyrimidine derivatives, method for preparation thereof and antiviral pharmaceutical composition comprising the same (2007-10-02),
2. 7244731 - 6-Methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same (2007-07-17),
3. 6608058 - 6-methylnicotinamide derivatives as antiviral agents (2003-08-19),

Title: Innovations of Geun-Hyung Lee in Antiviral Pharmaceutical Development

Introduction

Geun-Hyung Lee is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of antiviral pharmaceuticals, particularly in the development of compounds effective against Hepatitis C virus (HCV). With a total of three patents to his name, his work showcases innovative approaches to combating viral infections.

Latest Patents

One of Geun-Hyung Lee's latest patents is focused on 6-(4-substituted-anilino)pyrimidine derivatives. This invention relates to compounds that exhibit an excellent inhibitory effect on the replication of Hepatitis C virus. The derivatives are characterized by a specific formula where R represents various alkoxycarbonyl groups, heterocycliccarbonyl groups, or carboxyalkyl groups. These compounds can be utilized as therapeutic or prophylactic agents against hepatitis C.

Another significant patent involves 6-methylpyridine derivatives, which also serve as antiviral agents. Similar to his previous work, these derivatives demonstrate a strong inhibitory effect on HCV replication. The invention includes a method for preparing these compounds and outlines their potential use in antiviral pharmaceutical compositions.

Career Highlights

Geun-Hyung Lee has worked with reputable companies in the pharmaceutical industry, including B & C Biopharm and Dongwha Pharm. Ind. Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative antiviral solutions.

Collaborations

Throughout his career, Geun-Hyung Lee has collaborated with notable colleagues, including Sang-Wook Lee and Jong-Woo Kim. These partnerships have likely enhanced his research and development efforts in the field of antiviral pharmaceuticals.

Conclusion

Geun-Hyung Lee's contributions to antiviral pharmaceutical development, particularly in the context of Hepatitis C, highlight his innovative spirit and dedication to improving public health. His patents reflect a commitment to finding effective treatments for viral infections, showcasing the importance of research and innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…